246960 — SCL Science Balance Sheet
0.000.00%
- KR₩94bn
- KR₩107bn
- KR₩5bn
Annual balance sheet for SCL Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,638 | 10,421 | 4,821 | 9,045 | 1,114 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 525 | 239 | 204 | 1,073 | 2,474 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,519 | 10,858 | 5,469 | 10,546 | 5,453 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,680 | 10,460 | 13,882 | 15,774 | 9,788 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 17,351 | 31,883 | 30,814 | 30,158 | 24,057 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 836 | 657 | 2,465 | 3,356 | 3,457 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 4,408 | 21,804 | 17,769 | 11,255 | 8,540 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,943 | 10,079 | 13,045 | 18,903 | 15,517 |
| Total Liabilities & Shareholders' Equity | 17,351 | 31,883 | 30,814 | 30,158 | 24,057 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |